Drug Shortage Report for CADUET
Report ID | 201947 |
Drug Identification Number | 02273241 |
Brand name | CADUET |
Common or Proper name | CADUET |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN AMLODIPINE |
Strength(s) | 20MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | C10BX |
ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-08-22 |
Actual start date | 2023-08-10 |
Estimated end date | 2023-09-20 |
Actual end date | 2023-09-19 |
Shortage status | Resolved |
Updated date | 2023-09-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-09-26 | French | Compare |
v6 | 2023-09-26 | English | Compare |
v5 | 2023-09-20 | French | Compare |
v4 | 2023-09-20 | English | Compare |
v3 | 2023-08-23 | English | Compare |
v2 | 2023-08-16 | French | Compare |
v1 | 2023-08-16 | English | Compare |
Showing 1 to 7 of 7